Back
Pfizer Leads Price Hikes on 350 Drugs Despite US Pressure
Back
Stock News
Themes
Pfizer Leads Price Hikes on 350 Drugs Despite US Pressure
CAR-T Therapy
Pfizer Leads Price Hikes on 350 Drugs Despite US Pressure
Edgen Stock
·
Dec 31 2025, 13:34
Share to
Share to
Copy link
source:
[1] Defying Trump's Pressure, US to Raise Prices on 350 Prescription Drugs Next Year
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17